Literature DB >> 2109740

A comparison of in-house and regionalized computerized tomography scanning: clinical impact and cost.

A Elixhauser1, D M Reker, K N Gillespie, J Fletcher, F D Wolinsky.   

Abstract

Over a two-year interval, computerized tomography (CT) scans at an urban, 400-bed Department of Veterans Affairs medical center (VAMC) were obtained in three ways. First, an in-house low-efficiency machine was used. Then, scans were done at another area hospital, in effect duplicating some aspects of regionalizing services. Finally, a high-efficiency in-house machine was used. Clinical outcomes and costs of diagnosing 181 bronchogenic cancer patients were compared across the three time periods to identify any differences associated with regionalization of CT services. Patient groups were homogeneous with respect to sociodemographic characteristics, clinical presentation, and severity of disease. The first part of the analysis investigated whether the site of CT scanning affected clinical outcomes. Diagnostic procedures, surgical results, mortality, and length of stay were compared using one-way analysis of variance. Significant differences were found only for conventional tomography and CT utilization rates. While conventional tomography declined across the periods, CT utilization increased, exceeding national trends. The second part of the analysis examined the costs of CT scanning. During the regionalized period, the hospital paid a fixed fee of $519 per scan. Estimated costs of in-house scans were $285 in the low-efficiency and $141 in the high-efficiency periods. Charge-based payments made to the external facility and differences in the volumes of patients scanned internally account for the cost differences. The analysis showed that while regionalized CT scanning did not compromise the quality of care for these VA patients, it was more costly. Results suggest that VA hospital administrators should carefully consider ownership and payment arrangements when comparing regionalized and in-house provision of services.

Entities:  

Mesh:

Year:  1990        PMID: 2109740      PMCID: PMC1065620     

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  15 in total

1.  The impact of computed tomography on the care of patients with suspected brain tumor.

Authors:  E B Larson; G S Omenn
Journal:  Med Care       Date:  1977-07       Impact factor: 2.983

2.  Impact of new technology: the CT scanner.

Authors:  W A Knaus; S A Schroeder; D O Davis
Journal:  Med Care       Date:  1977-07       Impact factor: 2.983

3.  Computed tomography: cost and efficacy implications.

Authors:  H L Abrams; B J McNeil
Journal:  AJR Am J Roentgenol       Date:  1978-07       Impact factor: 3.959

4.  Cranial computed tomography: An evaluation of cost effectiveness.

Authors:  G Wortzman; R C Holgate; P P Morgan
Journal:  Radiology       Date:  1975-10       Impact factor: 11.105

5.  Utilization, reliability, and cost effectiveness of cranial computed tomography in evaluating pseudotumor cerebri.

Authors:  R G Evens; N Rujanavech; M A Mikhael
Journal:  AJR Am J Roentgenol       Date:  1977-08       Impact factor: 3.959

6.  Computed tomography in lung cancer.

Authors:  P J Friedman
Journal:  Am J Surg       Date:  1982-06       Impact factor: 2.565

7.  Effectiveness of CT in evaluating intrathoracic masses.

Authors:  P J Sones; W E Torres; R S Colvin; W L Meier; P Sprawls; J V Rogers
Journal:  AJR Am J Roentgenol       Date:  1982-09       Impact factor: 3.959

8.  The diffusion of the computed tomography (CT) scanner in the United States.

Authors:  H D Banta
Journal:  Int J Health Serv       Date:  1980       Impact factor: 1.663

9.  Duplicated hospital facilities: How much can we save by consolidating them?

Authors:  W B Schwartz; P L Joskow
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

10.  Evaluating cost-effectiveness of diagnostic equipment: the brain scanner case.

Authors:  J R Bartlett; G Neil-Dwyer; J M Banham; D G Cruickshank
Journal:  Br Med J       Date:  1978-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.